Cervical spondylosis and degenerative disc disease may result in compression of one or more nerve roots and/or the spinal cord. If non-operative treatment fails, anterior cervical discectomy and fusion (ACDF) is a common treatment for cervical radiculopathy and myelopathy [1]. The procedure shows high patient satisfaction scores and a 95 % arthrodesis rate [2, 3]. Nevertheless the technique causes a loss of segmental motion and a possible need for reoperation because of pseudoarthrosis or adjacent segment degeneration (ASD). In recent years, cervical disc replacement (CDR) has become popular as an alternative to ACDF. Its theoretical and observed advantages include a more physiologic distribution of range of motion (ROM), reduced adjacent level stresses and a lowered rate of ASD. Currently, there are many commercially available artificial discs with different biomechanical properties [3–7].

This study reports the first results of a prospective, two-centre observational clinical trial on a newly developed artificial disc replacement device. There are currently no long term reports about the ROTAIO Cervical Disc Prosthesis (SIGNUS Medizintechnik GmbH, Alzenau, Germany). The study objective was to evaluate the clinical and radiological outcome after a maximum follow up of two years and to compare the results to available data of other artificial disc devices.

The observation was institutional review board approved (Ethics Commission, Medical University Innsbruck – Austria). All patients at the two centres who met the inclusion/exclusion criteria provided written informed consent and were included in the trial. Patient selection was based on the following inclusion and exclusion criteria. Inclusion criteria: (1) 18 to 65 years of age, (2) a single cervical disc disease between the level C3 and C7, (3) failed conservative treatment of at least 6 weeks or in case of progressive nerve root or spinal cord compression and (4) a minimum Neck Disability Index (NDI) of 15 points (30 %). Exclusion criteria: (1) cervical instability defined by translation on flexion–extension radiographs compared to the adjacent level, (2) non-mobility of the level, (3) fused adjacent levels, (4) neck pain as the solitary symptom, (5) prior surgery at target level, (6) metabolic bone disease or endocrine disorders, (7) pregnancy, (8) traumatic injury of spine, (9) HIV, metastatic cancer, presence of infection and (10) allergy to materials used in the device.

Device design

The ROTAIO Cervical Disc Prosthesis (Fig. 1) is intended to be used for disc replacement in the cervical spine (C3-C7). In addition to restoring disc height, its primary function is to maintain physiological movement in the affected segment. The ROTAIO Cervical Disc Prosthesis represents a new unconstrained implant with a variable centre of rotation which should enable physiological facet-guided movement. For maximum coverage of the vertebral body end plates a total of 16 different sizes are available with various surface areas and heights. The prosthesis is pre-mounted on an insertion bracket to avoid the need for intraoperative assembly. Instruments specially developed for use with the implant system are available to ensure safe application.

The prosthesis consists of a superior and an inferior end plate (Titanium alloy to ISO 5832-3) on which the sliding elements (Cobalt-chrome alloy to ISO 5832-12) are anchored and secured by means of a fixation pin. The implant design provides an optimum fit to the anatomy of the intervertebral space. Assembly of ROTAIO is done in an axial direction. This has the effect that the slide plate is radially surrounded by the cover plate, which prevents the sliding plate from dislodgement. For optimum primary stabilization the end plates have a toothed surface. A special blasting treatment of the end plates increases surface area and thus bony integration.

ACDF is a successful treatment and has shown high patient satisfaction rates for years. During the last two decades the effectiveness of CDR in treating cervical degenerative disc diseases has been analysed and in summary CDR after anterior neurological decompression may be deemed as an alternative to fusion in selected patients [5, 8–11]. Till now biomechanics, clinical and radiological effectiveness of most current available artificial discs prosthesis have been studied [1, 4, 5, 12–14]. As a newly established device the ROTAIO cervical disc prosthesis has only been in use for a few years. This is the first prospective study that analyses its clinical and radiographic reliability.

The results of this study demonstrated promising clinical and radiological outcomes. Concerning the NDI the observation showed a significant improvement of 51.5 % (p < 0.001) after implantation which correlates with present studies of other available cervical disc prosthesis [4–6]. Analysis of VAS showed a significant reduction of neck and arm pain early after surgery which might primarily be related to sufficient decompression during surgery and the in-hospital pain management. At last follow-up the improvement of arm and neck pain was significant as well and was also confirmed by a significant reduction of used NSAIDs. Regarding overall satisfaction 95.7 % of the patients achieved good to excellent improvement which is in-line with reports that observed the early results of other established cervical disc prostheses and also ACDFs [1, 3, 5, 8, 9, 11, 15–18]. High patient satisfaction rates were also reinforced by evaluating the PSI which has shown that 77.3 % of the patients would definitely have liked to have the same treatment for the same ailment again at the last follow up.

According to prior clinical trials of cervical arthroplasty subsequent secondary surgical intervention was defined as any revision, removal, reoperation or supplemental fixation [1, 4–6]. Until the last follow-up in one case (2.2 %) an increase of neck and arm pain was observed and subsequent secondary surgical intervention was required to remove a probably undersized prosthesis. As published by Sasso et al [1], Burkus et al [7] and Anderson and Hashimoto [19] for other disc prostheses the results of this study show a very low rate of secondary procedures and no prostheses related complications during or after surgery. According to Li et al [6] proper selection of patients, exact intraoperative strategy and adequate neural decompression is required to achieve satisfactory clinical outcomes.

Radiographic analysis showed no dislocation, anterior migration or malfunction of the prosthesis. As reported by Heller et al ROM values measured radiographically can be influenced by the radiographic technique itself, patient´s motivation or other – unknown – factors [5]. Nevertheless most authors observed motion preservation at the implanted level and characterized it as one of the fundamental benefits of CDR [1, 3, 4, 16, 20]. In the present study the prosthesis maintained physiological segmental motion with a mean flexion-extension difference of 8.4° in the 3 to 6 month visit and 8.6° at the last follow-up. According to Heller et al [4] an increasing ROM probably is a sign of less pain and higher patient´s motivation. Additionally a restored lordotic sagittal alignment was observed in all cases thus compared to other available CDR devices the ROTAIO prosthesis does not show a lordotic design like e.g. the Discover disc [6]. A fact that might be an advantage over prostheses like the Bryan disc, for which segmental kyphosis of the index level – persisting for more than 6 months postoperatively - was reported by Pickett et al [20]. The radiographic analysis also showed a low rate (2.2 %) of spontaneous fusion as measured by presence of bridging bone. This result may be a consequence of the preserved ROM but according to the works of Heller et al [5] it could also be influenced by patient selection. The authors describe that patients with significant spondylosis may have a greater likelihood of spontaneous fusion [5].

Adjacent segment disease (ASD) following uninstrumented ACDF has been reported to occur in 25 % of patients within 10 years and shows an incidence of 2.9 % per year [21, 22]. Based on the rationale that CDR helps to preserve the biomechanics of the spine in the index level and in addition also in the adjacent segments the potential for decreasing ASD was one of the most striking arguments for total disc arthroplasty. As reported by Riew et al [22] it is quite challenging to compare rates of radiographic or symptomatic ASD across the available literature because authors use substantially different definitions for their analysis and because there is no direct relationship between radiographic and symptomatic ASD. In the present study radiographic ASD was defined as new anterior osteophyte formation or enlargement of existing osteophytes and the rate of reoperation at the level directly adjacent to the treated level. In one case (2.2 %) anterior bridging bone at the index level and new osteophyte formations in the adjacent cranial level was observed. The low rate of ASD goes in line with the results of other authors and may be artificially low because of the definition as mentioned above and the follow up with a maximum period of just 24 month [1, 7, 22, 23] thus e.g. Park et al [24] reported that adjacent-level anterior disc space ossification (ALOD) occurs within the first 12 months after treatment and that patients with no ossification at 24 months are very unlikely to progress to advanced ossification. Furthermore - according to the work of Nunley et al [25] – over and above the device design there may be lots of different factors influencing the development of an ASD like e.g. age, sex, smoking habit or coexisting diseases.

Concerning the development of symptomatic ASD the results of this study show a mild increase of the mean VAS regarding neck pain from the 6 months visit to the last follow up ( 2.42 to 3.33; p > 0.05). Nevertheless this may be associated to the prosthesis or may be a part of degenerative spine´s natural history, long-term follow-up is necessary to evaluate if differences in adjacent segment motion and radiographical degeneration will affect the development of clinical ASD. To what extent the new design of the ROTAIO cervical disc prosthesis is able to reduce the risk of ASD and how far the device could protect the uncovertebral and facet joints from overload must be the aim of upcoming biomechanical analysis.

Overall new technology such as artificial disc devices requires long-term follow up to assess durability, the biologic compatibility and the response of the prosthesis to its environment. Typically failure of other joint arthroplasty does not occur before five to ten years after surgery. Therefore spinal disc prostheses similarly need to be assessed repetitively and for a longer period [1, 18]. Nevertheless based on clinical outcome according to the significant reduction of NDI and VAS scores, the high overall satisfaction and the evaluated safety of the device the ROTAIO prosthesis may be deemed as a good alternative for currently available cervical disc prostheses.

The early results of this prospective, observational study show that cervical disc arthroplasty with the ROTAIO Cervical Disc Prosthesis seems to be safe and effective for the treatment of symptomatic single-level degenerative disc disease. Additionally patients had significantly improved NDI and VAS scores, showed a lower rate of NSAID-use and an excellent overall success at last follow-up. Thus, according to recent studies of other cervical disc prostheses the results confirm and support the role of total disc replacement as an alternative to ACDF, studies focusing on clinical long-term outcome and especially on preserving ASD are warranted.